| Primary |
| Colorectal Cancer Metastatic |
20.2% |
| Metastatic Colorectal Cancer |
12.1% |
| Product Used For Unknown Indication |
11.0% |
| Colon Cancer |
8.1% |
| Drug Use For Unknown Indication |
6.9% |
| Chemotherapy |
4.6% |
| Colorectal Cancer |
4.6% |
| Pancreatic Carcinoma |
4.6% |
| Rectal Cancer |
4.0% |
| Adenocarcinoma Of Colon |
3.5% |
| Colon Cancer Metastatic |
3.5% |
| Metastatic Carcinoma Of The Bladder |
2.9% |
| Prophylaxis Of Nausea And Vomiting |
2.9% |
| Metastases To Liver |
2.3% |
| Metastatic Colon Cancer |
1.7% |
| Neoplasm Malignant |
1.7% |
| Stomach Cancer |
1.7% |
| Candida Infection |
1.2% |
| Colon Cancer Stage Iii |
1.2% |
| Gastric Cancer Stage Iv |
1.2% |
|
| Pyrexia |
15.6% |
| Paraesthesia |
9.4% |
| Interstitial Lung Disease |
6.3% |
| Liver Injury |
6.3% |
| Respiratory Failure |
6.3% |
| Thrombocytopenia |
6.3% |
| Urinary Tract Infection |
6.3% |
| Vomiting |
6.3% |
| Anaemia |
3.1% |
| Cardiovascular Disorder |
3.1% |
| Confusional State |
3.1% |
| Deep Vein Thrombosis |
3.1% |
| Device Related Infection |
3.1% |
| Drug Interaction |
3.1% |
| Extravasation |
3.1% |
| Febrile Neutropenia |
3.1% |
| General Physical Health Deterioration |
3.1% |
| Hepatitis B |
3.1% |
| Hypersensitivity |
3.1% |
| Hypotension |
3.1% |
|
| Secondary |
| Colon Cancer |
29.7% |
| Colorectal Cancer |
19.3% |
| Colorectal Cancer Metastatic |
12.7% |
| Lymphoma |
8.8% |
| Prophylaxis |
6.0% |
| Rectal Cancer |
3.8% |
| Hypertension |
2.8% |
| Adenocarcinoma |
2.1% |
| Drug Use For Unknown Indication |
1.6% |
| Product Used For Unknown Indication |
1.5% |
| Vomiting |
1.5% |
| Folate Deficiency |
1.4% |
| Pancreatic Carcinoma |
1.3% |
| Pain |
1.2% |
| Prophylaxis Of Nausea And Vomiting |
1.2% |
| Constipation |
1.2% |
| Premedication |
1.1% |
| Colon Cancer Metastatic |
1.1% |
| B-cell Lymphoma |
0.9% |
| Breast Cancer Metastatic |
0.9% |
|
| Disease Progression |
13.8% |
| Vomiting |
11.6% |
| Death |
7.5% |
| Intestinal Obstruction |
6.7% |
| Pulmonary Embolism |
6.3% |
| Erythrosis |
6.0% |
| Neutropenia |
4.9% |
| Pyrexia |
4.9% |
| Tachycardia Paroxysmal |
4.5% |
| Thrombocytopenia |
4.5% |
| Anal Abscess |
3.4% |
| Diarrhoea |
3.4% |
| Respiratory Failure |
3.4% |
| General Physical Health Deterioration |
3.0% |
| Jugular Vein Thrombosis |
3.0% |
| Neurotoxicity |
3.0% |
| Electrocardiogram St Segment Depression |
2.6% |
| Epistaxis |
2.6% |
| Hypovolaemia |
2.6% |
| Nervous System Disorder |
2.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
20.0% |
| Rheumatoid Arthritis |
10.6% |
| Product Used For Unknown Indication |
9.4% |
| Colon Cancer |
7.8% |
| Hiv Infection |
6.7% |
| Prophylaxis |
6.0% |
| Premedication |
5.4% |
| Colorectal Cancer Metastatic |
5.0% |
| Hypertension |
4.6% |
| Rectal Cancer |
4.0% |
| Acute Lymphocytic Leukaemia |
3.0% |
| Infection |
2.6% |
| Central Nervous System Lymphoma |
2.4% |
| Cerebral Toxoplasmosis |
2.2% |
| Colon Cancer Metastatic |
2.1% |
| Infection Prophylaxis |
1.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.8% |
| Bone Marrow Conditioning Regimen |
1.7% |
| Prophylaxis Against Graft Versus Host Disease |
1.6% |
| Colorectal Cancer |
1.4% |
|
| Thrombocytopenia |
9.7% |
| White Blood Cell Count Decreased |
9.0% |
| Renal Failure Acute |
7.6% |
| Pyrexia |
6.9% |
| Sepsis |
6.2% |
| Pyothorax |
5.5% |
| Vomiting |
5.5% |
| Muscular Weakness |
4.8% |
| Diarrhoea |
4.1% |
| Neuroendocrine Carcinoma |
4.1% |
| Rash |
4.1% |
| Septic Shock |
4.1% |
| Stomatitis |
4.1% |
| Urticaria |
4.1% |
| Crohn's Disease |
3.4% |
| Myocardial Infarction |
3.4% |
| Pulmonary Embolism |
3.4% |
| Rectal Haemorrhage |
3.4% |
| White Blood Cell Count Increased |
3.4% |
| Dyspnoea |
2.8% |
|
| Interacting |
| Drug Use For Unknown Indication |
38.9% |
| Rectal Cancer |
33.3% |
| Colorectal Cancer Metastatic |
16.7% |
| Premedication |
11.1% |
|
| Lower Limb Fracture |
75.0% |
| Transaminases Increased |
25.0% |
|
